YouTube Facebook LinkedIn Google+ Twitter Xingrss  

AstraZeneca Cuts More Jobs; Signs $240M+ Agreement with Moderna


March 21, 2013 | Lots of news for AstraZeneca this morning. The company announced plans to cut 2300 sales and administrative jobs just days after announcing 1600 cuts to research positions. In a statement this morning, the big pharma said it plans to focus on  three main research areas: respiratory, inflammation & autoimmunity; cardiovascular & metabolic disease; and oncology. "We will continue to be active in Infection & Vaccines and in Neuroscience, though our investments will be more opportunity-driven," the company said. AstraZeneca also announced a major agreement with Moderna Therapeutics, starting with a $240 million upfront payment. The Cambridge, Mass.-based company focuses on mRNA research and plans to triple its workforce immediately (Xconomy).
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.